GLP-1 weight loss treatment can be pricey. But employers who cover the treatments could end up saving on employee medical expenses overall. The finding is according to a new analysis of health insurance claims by global professional services firm, Aon, released Wednesday. The report looked at data for more than 50 million commercially insured people … Read more
submitted by /u/bevatsulfieten [link] [comments]
Covering the cost of pricey GLP-1 weight loss drugs could pay off for employers by cutting overall medical spending for people taking the medications, but not until year two, according to a massive analysis of health insurance claims by Aon released on Wednesday. Read more…
MONTREAL–(BUSINESS WIRE)–Innovaccer, the leading healthcare AI company, today announced that its recently acquired actuarial science company – Humbi AI, in collaboration with Landmark Science, Inc., will present a joint research at the upcoming International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2025 annual conference, scheduled to take place between May 13–16 in Montreal, QC, Canada. … Read more
Novo Nordisk strikes telehealth deals for obesity drug, following Eli Lilly statnews.com Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 23% CNBC Hims & Hers stock jumps on Novo Nordisk GLP-1 partnership Yahoo Finance Why New Wegovy Deals Won’t Restore Novo Nordisk’s Obesity Lead WSJ Novo Nordisk expands patient access to authentic, FDA-approved … Read more
Gen Alpha (children 14 and younger) led the rise of GLP-1 utilization from 2023 to 2024, with an 85% growth rate in that period. But what is behind the sharp increase? 3 factors at play There are several factors behind increased GLP-1 utilization in children. 1. The first is the obesity epidemic. About one-third of … Read more
Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for meats or fried foods, and scientists are beginning to figure out why
As broader approval for GLP-1 weight loss drugs spurs higher demand, it’s also causing employer drug spending to spike.
All it takes to change a pest to a partner is a signature on a dotted line. Danish pharmaceutical giant Novo Nordisk, the maker of leading weight-loss drug Wegovy, is signing a deal with online telehealth storefronts that ate a chunk of its business selling cheap knockoffs during shortages last year. Slimmed-Down Offering Novo Nordisk’s … Read more
GLP-1s can help employers lower medical costs in 2 years, new study finds CNBC Aon Unveils First Workforce-Focused Analysis on GLP-1s: Medications and Holistic Support Can Transform Workforce Health and Bend the Cost Curve Yahoo Finance GLP-1s are evolving — How benefit managers can prepare Employee Benefit News Wondr Health Launches GLP-1 Support For All Benefit Plans HIT Consultant … Read more